BR112014012414A8 - processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas - Google Patents
processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídasInfo
- Publication number
- BR112014012414A8 BR112014012414A8 BR112014012414A BR112014012414A BR112014012414A8 BR 112014012414 A8 BR112014012414 A8 BR 112014012414A8 BR 112014012414 A BR112014012414 A BR 112014012414A BR 112014012414 A BR112014012414 A BR 112014012414A BR 112014012414 A8 BR112014012414 A8 BR 112014012414A8
- Authority
- BR
- Brazil
- Prior art keywords
- pyrazolopyridines
- fluoro
- substituted
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
- C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/02—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms
- C07C317/04—Sulfones; Sulfoxides having sulfone or sulfoxide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/023—Preparation; Separation; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/037—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements with quaternary ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR122020001312-5A BR122020001312B1 (pt) | 2011-11-25 | 2012-11-21 | Processo para preparação de 5-flúor-1h-pirazolopiridinas substituídas, e compostos intermediários |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11190789 | 2011-11-25 | ||
EP11190789.5 | 2011-11-25 | ||
EP11192301 | 2011-12-07 | ||
EP11192301.7 | 2011-12-07 | ||
PCT/EP2012/073276 WO2013076168A1 (de) | 2011-11-25 | 2012-11-21 | Verfahren zur herstellung von substituierten 5-fluor-1h-pyrazolopyridinen |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112014012414A2 BR112014012414A2 (pt) | 2017-06-06 |
BR112014012414A8 true BR112014012414A8 (pt) | 2018-01-23 |
BR112014012414B1 BR112014012414B1 (pt) | 2022-01-11 |
Family
ID=47222101
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122020001312-5A BR122020001312B1 (pt) | 2011-11-25 | 2012-11-21 | Processo para preparação de 5-flúor-1h-pirazolopiridinas substituídas, e compostos intermediários |
BR112014012414-0A BR112014012414B1 (pt) | 2011-11-25 | 2012-11-21 | Processos para preparar 5-flúor-1h-pirazolopiridinas substituídas |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR122020001312-5A BR122020001312B1 (pt) | 2011-11-25 | 2012-11-21 | Processo para preparação de 5-flúor-1h-pirazolopiridinas substituídas, e compostos intermediários |
Country Status (42)
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010021637A1 (de) | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
DE102010043379A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung |
DE102010043380A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Benzyl-substituierte Carbamate und ihre Verwendung |
DK3421470T3 (da) | 2011-11-25 | 2021-04-06 | Adverio Pharma Gmbh | Substituerede 5-fluor-1h-pyrazolopyridiner i krytallinsk form |
KR20150119871A (ko) | 2013-02-21 | 2015-10-26 | 아드베리오 파마 게엠베하 | 메틸 {4,6-디아미노-2-[1-(2-플루오로벤질)-1H-피라졸로[3,4-b]피리디노-3-일]피리미디노-5-일}메틸 카르바메이트의 형태 |
JO3318B1 (ar) | 2013-06-18 | 2019-03-13 | Lilly Co Eli | مثبطات bace |
EP3389655A2 (en) | 2015-12-14 | 2018-10-24 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION |
WO2018111795A2 (en) | 2016-12-13 | 2018-06-21 | Ironwood Pharmaceuticals, Inc. | Use of sgc stimulators for the treatment of esophageal motility disorders |
AU2018252099B2 (en) | 2017-04-11 | 2021-08-12 | Sunshine Lake Pharma Co., Ltd. | Fluorine-substituted indazole compounds and uses thereof |
US20210177846A1 (en) | 2018-07-11 | 2021-06-17 | Cyclerion Therapeutics, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS |
MX2021007090A (es) * | 2018-12-17 | 2021-08-11 | Adverio Pharma Gmbh | Producto del compuesto activo {4,6-diamino-2-[5-fluoro-1-(2-fluoro bencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo que tiene propiedades mejoradas, produccion y formulacion del mismo. |
WO2020152010A1 (en) | 2019-01-22 | 2020-07-30 | Adverio Pharma Gmbh | Process for manufacturing 4-(2,2,3,3-tetrafluoropropyl)morpholine |
WO2021156223A1 (en) | 2020-02-03 | 2021-08-12 | Adverio Pharma Gmbh | Nanoformulations of methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate |
EP3925953A1 (en) | 2020-06-16 | 2021-12-22 | Adverio Pharma GmbH | Process for preparing methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate |
WO2023034364A1 (en) | 2021-08-31 | 2023-03-09 | Teva Pharmaceuticals International Gmbh | Solid state forms of vericiguat and process for preparation thereof |
ES2956054A1 (es) | 2022-05-03 | 2023-12-12 | Moehs Iberica Sl | 2-(5-FLUORO-1-(2-FLUOROBENCIL)-1H-PIRAZOLO[3,4-b]PIRIDIN-3-IL)-5-NITROSOPIRIMIDIN-4,6-DIAMINA O UNA SAL DE LA MISMA, PROCEDIMIENTO PARA SU PREPARACION Y SU USO EN LA SINTESIS DE VERICIGUAT |
CN115043835B (zh) * | 2022-06-17 | 2023-05-09 | 常州制药厂有限公司 | 一种维立西呱的精制纯化方法 |
WO2024038398A1 (en) * | 2022-08-18 | 2024-02-22 | Torrent Pharmaceuticals Limited | Novel salt of substituted 5-fluoro-1h-pyrazolopyridines and its uses |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8606936D0 (en) * | 1986-03-20 | 1986-04-23 | Ici Plc | Organic compounds |
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
DE19642255A1 (de) | 1996-10-14 | 1998-04-16 | Bayer Ag | Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten |
DE59713007D1 (de) | 1996-10-14 | 2009-06-25 | Bayer Healthcare Ag | Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen |
US6451805B1 (en) | 1997-11-14 | 2002-09-17 | Bayer Aktiengesellschaft | Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19834045A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | (4-Amino-5-ethylpyrimidin-2-yl)-1-(2-fluorbenzyl)-1H-pyrazolo[3,4-b]pyridin |
DE19846514A1 (de) | 1998-10-09 | 2000-04-20 | Bayer Ag | Neue Heterocyclyl-methyl-substituierte Pyrazole |
TR200101359T2 (tr) | 1998-11-16 | 2001-11-21 | Basf Aktiengesellschaft | 3-[Benz(Ok/Otı)Azol-7-İl]-1H-Pirimidin-2,4-Dionlar |
DE19920352A1 (de) | 1999-05-04 | 2000-11-09 | Bayer Ag | Substituiertes Pyrazolderivat |
ES2231581T3 (es) | 2000-11-22 | 2005-05-16 | Bayer Healthcare Ag | Nuevos derivados de pirazolopiridina sustituidos con lactama. |
AR031176A1 (es) * | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
DE10057754A1 (de) | 2000-11-22 | 2002-05-23 | Bayer Ag | Neue Sulfonamid-substituierte Pyrazolopyridinderivate |
DE10057751A1 (de) | 2000-11-22 | 2002-05-23 | Bayer Ag | Neue Carbamat-substituierte Pyrazolopyridinderivate |
DE10131987A1 (de) | 2000-11-22 | 2002-05-23 | Bayer Ag | Neue Pyridin-substituierte Pyrazolopyridinderivate |
DE10122894A1 (de) | 2001-05-11 | 2002-11-14 | Bayer Ag | Neue Sulfonat-substituierte Pyrazolopyridinderivate |
ME00412B (me) | 2001-06-22 | 2011-10-10 | Boehringer Ingelheim Pharma | Kristalni antiholinergik , postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka |
DE10132416A1 (de) | 2001-07-04 | 2003-01-16 | Bayer Ag | Neue Morpholin-überbrückte Pyrazolopyridinderivate |
DE10153737A1 (de) | 2001-10-31 | 2003-05-28 | Boehringer Ingelheim Pharma | Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
DE10220570A1 (de) * | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
DE10222550A1 (de) | 2002-05-17 | 2003-11-27 | Bayer Ag | Substituierte Benzyl-pyrazolopyridine |
DE10232572A1 (de) | 2002-07-18 | 2004-02-05 | Bayer Ag | Neue 2,5-disubstituierte Pyrimidinderivate |
DE10232571A1 (de) | 2002-07-18 | 2004-02-05 | Bayer Ag | 4-Aminosubstituierte Pyrimidinderivate |
DE10351903A1 (de) | 2003-11-06 | 2005-06-09 | Bayer Healthcare Ag | Neue Kombination |
DE102006021733A1 (de) * | 2006-05-09 | 2007-11-22 | Bayer Healthcare Ag | 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung |
DE102006031175A1 (de) | 2006-07-06 | 2008-01-10 | Bayer Healthcare Ag | Wässrige Arzneimittelformulierung von 4-[((4-Carboxybutyl)-(2[(4-phenethyl-benzyl)oxy]-phenethyl)amino)methyl]benzoesäur |
DE102006043443A1 (de) | 2006-09-15 | 2008-03-27 | Bayer Healthcare Ag | Neue aza-bicyclische Verbindungen und ihre Verwendung |
WO2009000832A2 (en) | 2007-06-25 | 2008-12-31 | Boehringer Ingelheim International Gmbh | Chemical compounds |
EP2176261B1 (en) | 2007-07-31 | 2012-12-19 | Vertex Pharmaceuticals Incorporated | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
JP2011513483A (ja) | 2008-03-10 | 2011-04-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | タンパク質キナーゼの阻害剤として有用なピリミジンおよびピリジン |
KR100979460B1 (ko) * | 2008-05-13 | 2010-09-02 | 한국과학기술연구원 | 함불소알킬그룹이 치환된 이온성 액체의 직접 제조방법 |
DE102009004245A1 (de) | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung |
UY33040A (es) * | 2009-11-27 | 2011-06-30 | Bayer Schering Pahrma Akitengesellschaft | Nuevas formas polimorfas de {4,6diamino-2-[1-(2-fluorobencil-1h-pirazol[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo |
KR101766931B1 (ko) | 2009-11-27 | 2017-08-09 | 아드베리오 파마 게엠베하 | 제약상 물질로서 사용하기 위한 메틸-(4,6-디아미노-2-(1-(2-플루오로벤질)-1h-피라졸로(3,4-b)피리디노-3-일)피리미디노-5-일)메틸카르바메이트의 제조 방법 및 그의 정제 |
UY33041A (es) * | 2009-11-27 | 2011-06-30 | Bayer Schering Pharma Aktienegesellschaft | Procedimiento para la preparaciòn de {4,6-diamino-2-[1-(2-fluorobencil)-1h-pirazolo[3,4-b]piridin-3-il]pirimidin-5-il}carbamato de metilo y su purificaciòn para el uso como principio activo farmacèutico |
US20130178475A1 (en) | 2010-03-17 | 2013-07-11 | Ironwood Pharmaceuticals, Inc. | sGC STIMULATORS |
DE102010021637A1 (de) * | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
BR112013000596A2 (pt) | 2010-07-09 | 2019-09-24 | Bayer Intelectual Property Gmbh | piridinas e tiazinas fusionadas e seus usos. |
DE102010040234A1 (de) | 2010-09-03 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur Herstellung von 5-Flour-1H-pyrazolo[3,4-b]pyridin-3-carbonitril |
DE102010040233A1 (de) | 2010-09-03 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Bicyclische Aza-Heterocyclen und ihre Verwendung |
DE102010043379A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung |
DE102010043380A1 (de) | 2010-11-04 | 2012-05-10 | Bayer Schering Pharma Aktiengesellschaft | Benzyl-substituierte Carbamate und ihre Verwendung |
DE102011007272A1 (de) | 2011-04-13 | 2012-10-18 | Bayer Pharma Aktiengesellschaft | Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung |
PE20141582A1 (es) | 2011-09-02 | 2014-11-06 | Bayer Ip Gmbh | Pirimidinas anilladas sustituidas y uso de las mismas |
DK3421470T3 (da) * | 2011-11-25 | 2021-04-06 | Adverio Pharma Gmbh | Substituerede 5-fluor-1h-pyrazolopyridiner i krytallinsk form |
-
2012
- 2012-11-21 DK DK18178621.1T patent/DK3421470T3/da active
- 2012-11-21 EP EP15151593.9A patent/EP2896617B1/de active Active
- 2012-11-21 MY MYPI2018001783A patent/MY197904A/en unknown
- 2012-11-21 PE PE2014000713A patent/PE20142359A1/es active IP Right Grant
- 2012-11-21 CN CN201280066381.2A patent/CN104159898B/zh active Active
- 2012-11-21 CR CR20190057A patent/CR20190057A/es unknown
- 2012-11-21 PT PT12790891T patent/PT2782914T/pt unknown
- 2012-11-21 SI SI201231895T patent/SI3421470T1/sl unknown
- 2012-11-21 ES ES18178621T patent/ES2864009T3/es active Active
- 2012-11-21 EA EA201491028A patent/EA030018B1/ru not_active IP Right Cessation
- 2012-11-21 RS RS20161004A patent/RS55387B1/sr unknown
- 2012-11-21 AP AP2015008243A patent/AP3898A/en active
- 2012-11-21 PE PE2018003205A patent/PE20190181A1/es unknown
- 2012-11-21 MY MYPI2018001784A patent/MY198086A/en unknown
- 2012-11-21 SI SI201230770A patent/SI2896617T1/sl unknown
- 2012-11-21 PL PL12790891T patent/PL2782914T3/pl unknown
- 2012-11-21 ES ES12790891.1T patent/ES2694158T3/es active Active
- 2012-11-21 PT PT151515939T patent/PT2896617T/pt unknown
- 2012-11-21 MY MYPI2014701335A patent/MY168412A/en unknown
- 2012-11-21 UA UAA201703940A patent/UA119269C2/uk unknown
- 2012-11-21 KR KR1020197003426A patent/KR102026059B1/ko active IP Right Grant
- 2012-11-21 CR CR20210072A patent/CR20210072A/es unknown
- 2012-11-21 DK DK15151593.9T patent/DK2896617T3/en active
- 2012-11-21 CU CUP2015000124A patent/CU24354B1/es unknown
- 2012-11-21 WO PCT/EP2012/073276 patent/WO2013076168A1/de active Application Filing
- 2012-11-21 DK DK12790891.1T patent/DK2782914T3/en active
- 2012-11-21 SG SG10201604192XA patent/SG10201604192XA/en unknown
- 2012-11-21 LT LTEP12790891.1T patent/LT2782914T/lt unknown
- 2012-11-21 SG SG11201402111QA patent/SG11201402111QA/en unknown
- 2012-11-21 PL PL18178621T patent/PL3421470T3/pl unknown
- 2012-11-21 CA CA3040720A patent/CA3040720C/en active Active
- 2012-11-21 AU AU2012342547A patent/AU2012342547C1/en active Active
- 2012-11-21 PE PE2018003204A patent/PE20190180A1/es unknown
- 2012-11-21 CN CN201610014399.8A patent/CN105503867B/zh active Active
- 2012-11-21 LT LTEP15151593.9T patent/LT2896617T/lt unknown
- 2012-11-21 HU HUE15151593A patent/HUE031029T2/en unknown
- 2012-11-21 TR TR2018/16203T patent/TR201816203T4/tr unknown
- 2012-11-21 RS RS20210372A patent/RS61609B1/sr unknown
- 2012-11-21 EA EA201892050A patent/EA201892050A1/ru unknown
- 2012-11-21 SI SI201231439T patent/SI2782914T1/sl unknown
- 2012-11-21 JP JP2014542816A patent/JP6189315B2/ja active Active
- 2012-11-21 EA EA201690520A patent/EA033455B1/ru not_active IP Right Cessation
- 2012-11-21 HU HUE12790891A patent/HUE041592T2/hu unknown
- 2012-11-21 RS RS20181317A patent/RS57945B1/sr unknown
- 2012-11-21 PT PT181786211T patent/PT3421470T/pt unknown
- 2012-11-21 EA EA201690521A patent/EA031602B1/ru not_active IP Right Cessation
- 2012-11-21 PL PL15151593T patent/PL2896617T3/pl unknown
- 2012-11-21 CN CN201611138520.4A patent/CN106905314A/zh active Pending
- 2012-11-21 ES ES15151593.9T patent/ES2603028T3/es active Active
- 2012-11-21 CA CA2856706A patent/CA2856706C/en active Active
- 2012-11-21 EP EP18178621.1A patent/EP3421470B8/de active Active
- 2012-11-21 AP AP2014007705A patent/AP2014007705A0/xx unknown
- 2012-11-21 BR BR122020001312-5A patent/BR122020001312B1/pt active IP Right Grant
- 2012-11-21 KR KR1020147017000A patent/KR101993022B1/ko active IP Right Grant
- 2012-11-21 UA UAA201703936A patent/UA120278C2/uk unknown
- 2012-11-21 LT LTEP18178621.1T patent/LT3421470T/lt unknown
- 2012-11-21 KR KR1020177033016A patent/KR101943788B1/ko active IP Right Grant
- 2012-11-21 UA UAA201406974A patent/UA116623C2/uk unknown
- 2012-11-21 SG SG10201604196VA patent/SG10201604196VA/en unknown
- 2012-11-21 EP EP12790891.1A patent/EP2782914B1/de active Active
- 2012-11-21 MX MX2014006018A patent/MX357481B/es active IP Right Grant
- 2012-11-21 BR BR112014012414-0A patent/BR112014012414B1/pt active IP Right Grant
- 2012-11-21 HU HUE18178621A patent/HUE053745T2/hu unknown
- 2012-11-22 JO JOP/2012/0351A patent/JOP20120351B1/ar active
- 2012-11-23 UY UY0001034467A patent/UY34467A/es unknown
- 2012-11-23 AR ARP120104425A patent/AR088983A1/es active Pending
- 2012-11-23 TW TW101143843A patent/TWI597280B/zh active
- 2012-11-23 TW TW108113331A patent/TW201932465A/zh unknown
- 2012-11-23 TW TW105136776A patent/TWI631123B/zh active
- 2012-11-23 TW TW107124021A patent/TWI665198B/zh active
- 2012-11-23 TW TW107115179A patent/TWI659016B/zh active
- 2012-11-26 US US13/684,670 patent/US8802847B2/en active Active
-
2014
- 2014-05-13 IL IL232585A patent/IL232585A0/en active IP Right Grant
- 2014-05-19 ZA ZA2014/03613A patent/ZA201403613B/en unknown
- 2014-05-21 CU CUP2014000055A patent/CU24257B1/es unknown
- 2014-05-21 CR CR20140237A patent/CR20140237A/es unknown
- 2014-05-21 DO DO2014000112A patent/DOP2014000112A/es unknown
- 2014-05-22 EC ECIEPI20141627A patent/ECSP14001627A/es unknown
- 2014-05-22 CL CL2014001339A patent/CL2014001339A1/es unknown
- 2014-05-22 PH PH12014501160A patent/PH12014501160B1/en unknown
- 2014-05-23 CO CO14111814A patent/CO6960555A2/es unknown
- 2014-05-23 GT GT201400101A patent/GT201400101A/es unknown
- 2014-07-01 US US14/320,875 patent/US9150573B2/en active Active
-
2015
- 2015-05-14 HK HK15104551.6A patent/HK1203951A1/xx unknown
- 2015-06-29 PH PH12015501494A patent/PH12015501494B1/en unknown
- 2015-07-10 US US14/796,703 patent/US9604948B2/en active Active
- 2015-08-18 ZA ZA2015/05970A patent/ZA201505970B/en unknown
- 2015-09-15 CU CUP2015000123A patent/CU20150123A7/es unknown
-
2016
- 2016-02-12 CL CL2016000344A patent/CL2016000344A1/es unknown
- 2016-06-16 IL IL246265A patent/IL246265B/en active IP Right Grant
- 2016-09-20 JP JP2016182821A patent/JP6340391B2/ja active Active
- 2016-10-17 HK HK16111926.8A patent/HK1223613A1/zh unknown
- 2016-11-14 HR HRP20161501TT patent/HRP20161501T1/hr unknown
-
2017
- 2017-01-16 DO DO2017000013A patent/DOP2017000013A/es unknown
- 2017-02-17 US US15/435,964 patent/US9845300B2/en active Active
- 2017-11-02 AU AU2017254916A patent/AU2017254916B2/en active Active
- 2017-11-13 JP JP2017218037A patent/JP6392436B2/ja active Active
- 2017-11-14 US US15/812,524 patent/US10364229B2/en active Active
-
2018
- 2018-08-22 JP JP2018155294A patent/JP2018199698A/ja active Pending
- 2018-10-31 HR HRP20181818TT patent/HRP20181818T1/hr unknown
- 2018-11-29 IL IL263389A patent/IL263389B/en unknown
-
2019
- 2019-02-19 US US16/278,778 patent/US10633356B2/en active Active
- 2019-02-19 US US16/278,813 patent/US10633357B2/en active Active
- 2019-03-27 AU AU2019202123A patent/AU2019202123B2/en active Active
-
2021
- 2021-03-26 CY CY20211100270T patent/CY1124000T1/el unknown
- 2021-03-30 HR HRP20210507TT patent/HRP20210507T1/hr unknown
- 2021-04-05 JO JOP/2021/0064A patent/JOP20210064A1/ar unknown
- 2021-04-05 JO JOP/2021/0065A patent/JOP20210065A1/ar unknown
- 2021-08-25 DO DO2021000179A patent/DOP2021000179A/es unknown
-
2022
- 2022-02-24 UY UY0001039646A patent/UY39646A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014012414A2 (pt) | processo para a preparação de 5-flúor-1h-pirazolopiridinas substituídas | |
BR112014008196A2 (pt) | processo para a preparação de um composto | |
BR112014005322A2 (pt) | processo | |
BR112014004622A2 (pt) | processo para a preparação de isocianatos | |
BR112014016000A2 (pt) | processo | |
BR112014008911A2 (pt) | processo para a produção de 5-hidroximetilfurfural | |
BR112012014490A2 (pt) | processo para a preparação substituída de 1-o-acil-2-desóxi-2-fluoro-4-tio-beta-d-arabinofuranoses | |
BR112014012243A2 (pt) | processo de preparação de compostos | |
BR112013018945A2 (pt) | processo para a preparação de 4-amino-5-fluoro-3-halo-6-(substituído)picolinatos. | |
BR112013008883A2 (pt) | processo para a fabricação de di-hidropteridinonas | |
BR112013031120A2 (pt) | processo para a preparação de ácido fórmico | |
BR112015003101A2 (pt) | processo para a preparação de um composto. | |
BR112014016001A2 (pt) | processo | |
BR112013030423A2 (pt) | método para produção de biocoque | |
BR112014010997A2 (pt) | processo para o preparo de ß-glicosídeos de c-arila | |
BR112014015988A2 (pt) | processo | |
BR112013033184A2 (pt) | processo | |
BR112014001769A2 (pt) | processo para a preparação de 1,4-ciclo-hexanodimetanol | |
BR112014028589A2 (pt) | processo para fabricação de compostos de ciclopentilpirimidina hidroxilada | |
BR112014015999A2 (pt) | processo | |
BR112013022548A2 (pt) | processo para a preparação de aminas primárias | |
BR112014003336A2 (pt) | processo para a preparação de complexos de 68ga | |
BR112015000987A2 (pt) | processo para a preparação de 5-fluoro-1h-pirazóis | |
BR112014014052A2 (pt) | processo para a preparação de 5-hidroximetilfurfural | |
BR112012001731A2 (pt) | Processo para a preparação de 1-benzil-3-hidroximetil-1h-indazol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE) |
|
B25A | Requested transfer of rights approved |
Owner name: ADVERIO PHARMA GMBH (DE) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B25G | Requested change of headquarter approved |
Owner name: ADVERIO PHARMA GMBH (DE) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/11/2012, OBSERVADAS AS CONDICOES LEGAIS. |